GE Healthcare has introduced the Edison Digital Health platform, a vendor-agnostic hosting and data aggregation platform with an integrated artificial intelligence (AI) engine. The platform is being developed to enable hospitals and healthcare systems to effectively deploy clinical, workflow, analytics, and AI tools aimed at the improvement of care delivery, the promotion of high-efficiency operations, and the increase of revenue growth, while also supporting reduction in the IT burden that typically comes with installing and integrating apps across the enterprise.
Verily is working with Lumea, a digital pathology specialist, to improve prostate cancer pathology. The agreement brings together Verily’s artificial intelligence algorithms and Lumea’s end-to-end digital pathology platform with the objective to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.
One of medtech’s most anticipated devices has won approval in Europe. Dexcom received a CE mark for its G7 continuous glucose monitoring (CGM) system for people with diabetes over the age of two, including pregnant women. The company also plans to roll out an updated CGM algorithm this year.
And in case you missed our last Medtech in a Minute report...
Medtronic is leveraging Touch Surgery Enterprise, its AI-powered management and analytics platform for the operating room, developed by a division of the company's surgical robotics group. The contract with Vizient, a healthcare performance improvement company for nearly half the nation’s healthcare providers, expands Medtronic’s reach so the company can more easily implement Touch Surgery Enterprise in hospitals and clinics. A fully integrated hardware and software system connected to the cloud, Touch Surgery Enterprise works with many laparoscopic and robotic scopes and enables hospitals to take the first step to digitizing their operating room while using existing equipment.
Yet another device company is throwing in the towel for a special purpose acquisition corporation (SPAC) merger. Memic Innovative Surgery, a surgical robotics firm, and Medtech Acquisition Corps mutually nixed a merger because of market conditions and associated volatility related to recent world events. The proposed merger was first announced last August and would have given the combined company a $1 billion valuation.